openPR Logo
Press release

Glycated Haemoglobin Testing Market Extensive Growth Opportunities to be Witnessed by 2020

08-03-2017 12:20 PM CET | Health & Medicine

Press release from: Persistence Market Research

Glycated Haemoglobin Testing Market Extensive Growth

Haemoglobin is the red protein in blood cells which carry oxygen around the body. Haemoglobin A1c is a chemical form of glycated haemoglobin in order to test glucose level in the patients. Glycated haemoglobin test is used for diagnosis and monitoring of Haemoglobin A1c levels in diabetic patient. Glycated haemoglobin test reflects the average amount of glucose for the past 2 to 3 months in diabetic patients. It helps to determine the how well the level of glucose is controlled over time.

To View Complete Report @ : http://www.persistencemarketresearch.com/market-research/glycated-haemoglobin-testing-market.asp

North America dominates the global market for glycated haemoglobin testing due high diabetic prevalence and easily accessible modern healthcare facilities. Asia Pacific followed by the Europe is expected to show high growth rates in the next five years in global glycated haemoglobin testing market. Some of the key driving forces for glycated haemoglobin testing market in emerging countries are increasing prevalence of diabetics and increasing awareness about diabetics.

A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/3219

In recent times there is increased use of glycated haemoglobin testing due to increasing incidence of diabetics among the population. Growing awareness of haemoglobin A1c testing among patients and medical practitioners and aging population are some of the key factors driving the growth for global glycated haemoglobin testing market. In addition, increasing healthcare awareness is also fuelling the growth of global glycated haemoglobin testing market. However, presences of substitutes such as test strips, glucose meters, lancets and continuous blood glucose meter for monitoring diabetes and high test cost are some of the major factors restraining the growth for global glycated haemoglobin testing market.

To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/3219

Increasing healthcare facilities would lead to growth in glycated haemoglobin testing market in Asia. In addition, rapid commercialization of devices for diabetes testing would develop opportunity for global glycated haemoglobin testing market. However, presence of limited approval for assay of glycated haemoglobin testing could lead a challenge for global glycated haemoglobin testing market. Some of the trends for global glycated haemoglobin testing market are increasing mergers and acquisitions, which would help in improving measurement of glycated haemoglobin and point of care haemoglobin A1c testing. Some of the major companies operating in the global glycated haemoglobin testing market are Abbott Laboratories, Roche Holdings AG, Alere Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Bayer AG, ARKRAY Inc., Randox Laboratories Ltd., Tosoh Corp. and A. Menarini Diagnostics Ltd.

About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Glycated Haemoglobin Testing Market Extensive Growth Opportunities to be Witnessed by 2020 here

News-ID: 654092 • Views:

More Releases from Persistence Market Research

North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
Overview of the North America Wiring Devices Market The North America wiring devices market is poised for steady growth over the forecast period, with its size estimated at US$ 18.96 billion in 2024, projected to reach US$ 26.46 billion by 2031, reflecting a CAGR of 4.9%. The market is witnessing substantial expansion due to increasing urbanization, a rising number of residential and commercial construction projects, and the adoption of energy-efficient and
Global Forged Automotive Components Market Poised for Steady Growth, Projected to Reach US$ 70.7 Billion by 2032
Global Forged Automotive Components Market Poised for Steady Growth, Projected t …
The global forged automotive components market is on a robust growth trajectory, currently valued at approximately US$ 50.3 billion in 2025 and forecasted to expand to US$ 70.7 billion by the end of 2032. This growth represents a compound annual growth rate (CAGR) of 5.0% over the coming decade, driven by increasing automotive production, technological advancements, and evolving consumer preferences toward durable, high-performance vehicle parts. Forged automotive components are critical to
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ 2.14 Billion by 2032, Reports Persistence Market Research
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ …
The global electric cargo bike market is set to experience substantial growth over the coming decade, with Persistence Market Research (PMR) forecasting a compound annual growth rate (CAGR) of 11.9% from 2023 through 2032. Valued at approximately US$ 800 million in 2021, the market is expected to surge to a projected valuation of US$ 2.14 billion by the end of 2032. Notably, electric cargo bikes accounted for 66.2% of the
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Driven by Urbanization and Demographic Trends
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Drive …
The global bicycle bearings market is poised for significant expansion over the forecast period of 2025 to 2032, according to the latest report released by Persistence Market Research. Valued at approximately US$ 5.99 billion in 2024, the market is projected to reach US$ 6.35 billion by 2025 and further escalate to nearly US$ 9.86 billion by 2032. This growth trajectory reflects a compound annual growth rate (CAGR) of 6.5%, underscoring

All 5 Releases


More Releases for Haemoglobin

Glycated Haemoglobin Testing Market to Reach USD 6.2 Billion by 2034
The global burden of diabetes is increasing at an unprecedented rate, and effective monitoring of blood glucose levels has become critical in managing this chronic disease. Among the most reliable tools in diabetes care is glycated haemoglobin (HbA1c) testing, which measures average blood sugar levels over two to three months. Unlike daily glucose monitoring, HbA1c testing provides a long-term perspective, making it a gold standard for diagnosing and managing diabetes. Download
Haemoglobin Production Cost Report by Procurement Resource
Procurement Resource, a global leader in procurement intelligence and market analysis, is pleased to release its latest Haemoglobin Production Cost Report-a strategic tool for companies, researchers, investors, and healthcare manufacturers looking to explore or expand haemoglobin production capabilities. This detailed report delves into the technical, economic, and regulatory aspects of haemoglobin production, offering stakeholders a clear view of cost structures, raw material requirements, production routes, infrastructure, and profitability. With the growing
Glycated Haemoglobin Testing Equipment Market Size 2024 to 2031.
Market Overview and Report Coverage Glycated Haemoglobin Testing Equipment is used to measure the level of glycated hemoglobin in the blood, which is a crucial indicator for managing diabetes. The market for glycated haemoglobin testing equipment is expected to witness significant growth in the coming years, with a projected CAGR of 8.60% during the forecasted period. The increasing prevalence of diabetes worldwide, coupled with the rising awareness about the
Glycated Haemoglobin Testing Market Estimated to Record Highest CAGR by 2020
Haemoglobin is the red protein in blood cells which carry oxygen around the body. Haemoglobin A1c is a chemical form of glycated haemoglobin in order to test glucose level in the patients. Glycated haemoglobin test is used for diagnosis and monitoring of Haemoglobin A1c levels in diabetic patient. Glycated haemoglobin test reflects the average amount of glucose for the past 2 to 3 months in diabetic patients. It helps to
Global Glycated Haemoglobin Testing Market
The Glycated Haemoglobin Testing Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Haemoglobin is the red protein in blood cells which carry oxygen around the body. Haemoglobin A1c is a chemical form of glycated haemoglobin in order to test glucose level in
Analysis of Global Glycated Haemoglobin Testing Market by 2020
Haemoglobin is the red protein in blood cells which carry oxygen around the body. Haemoglobin A1c is a chemical form of glycated haemoglobin in order to test glucose level in the patients. Glycated haemoglobin test is used for diagnosis and monitoring of Haemoglobin A1c levels in diabetic patient. Glycated haemoglobin test reflects the average amount of glucose for the past 2 to 3 months in diabetic patients. It helps to